1. Home
  2. CYBN vs FXNC Comparison

CYBN vs FXNC Comparison

Compare CYBN & FXNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • FXNC
  • Stock Information
  • Founded
  • CYBN 2019
  • FXNC 1907
  • Country
  • CYBN Canada
  • FXNC United States
  • Employees
  • CYBN N/A
  • FXNC N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • FXNC Major Banks
  • Sector
  • CYBN Health Care
  • FXNC Finance
  • Exchange
  • CYBN Nasdaq
  • FXNC Nasdaq
  • Market Cap
  • CYBN 176.5M
  • FXNC 203.9M
  • IPO Year
  • CYBN N/A
  • FXNC N/A
  • Fundamental
  • Price
  • CYBN $5.94
  • FXNC $22.11
  • Analyst Decision
  • CYBN Strong Buy
  • FXNC
  • Analyst Count
  • CYBN 3
  • FXNC 0
  • Target Price
  • CYBN $85.00
  • FXNC N/A
  • AVG Volume (30 Days)
  • CYBN 700.6K
  • FXNC 18.5K
  • Earning Date
  • CYBN 11-12-2025
  • FXNC 10-31-2025
  • Dividend Yield
  • CYBN N/A
  • FXNC 2.84%
  • EPS Growth
  • CYBN N/A
  • FXNC N/A
  • EPS
  • CYBN N/A
  • FXNC 0.96
  • Revenue
  • CYBN N/A
  • FXNC $71,824,000.00
  • Revenue This Year
  • CYBN N/A
  • FXNC $57.18
  • Revenue Next Year
  • CYBN N/A
  • FXNC $5.15
  • P/E Ratio
  • CYBN N/A
  • FXNC $22.82
  • Revenue Growth
  • CYBN N/A
  • FXNC 46.30
  • 52 Week Low
  • CYBN $4.81
  • FXNC $18.25
  • 52 Week High
  • CYBN $13.88
  • FXNC $26.97
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 45.57
  • FXNC 40.53
  • Support Level
  • CYBN $5.93
  • FXNC $22.07
  • Resistance Level
  • CYBN $6.63
  • FXNC $23.28
  • Average True Range (ATR)
  • CYBN 0.32
  • FXNC 0.48
  • MACD
  • CYBN 0.03
  • FXNC -0.14
  • Stochastic Oscillator
  • CYBN 30.77
  • FXNC 25.00

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. Key revenue is generated from Community Banking.

Share on Social Networks: